Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enrique Gomez Gomez

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Current Opinion in Urology|September 25, 2023
Prognostic impact of serum testosterone in metastatic hormone-naive prostate cancer: a systematic review and meta-analysisIgnacio Puche-Sanz, Peter Chiu, Ana C Morillo, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|July 17, 2023
Midterm Outcomes of Kidney Transplantation from Expanded Criteria Donors After Circulatory Death: A Single-Center Retrospective Cohort StudyJoseba Salguero, Laura Chamorro, Enrique Gomez-Gomez, et al.
Scandinavian Journal of Urology|November 12, 2015
A tertiary experience of ileal-ureter substitution: Contemporary indications and outcomesEnrique Gomez-Gomez, Sachin Malde, Marco Spilotros, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|May 1, 2015
Perineostomy: the last oportunityJuan Carlos Regueiro Lopez, Enrique Gomez Gomez, Alberto Alonso Carrillo, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|February 26, 2025
Prognostic Significance of Programmed Cell Death-1, Programmed Cell Death-Ligand 1, Programmed Cell Death-Ligand 2, and Fibroblast Growth Factor Receptor 3 mRNA Expression in Bladder CancerAna Blanca, Antonio Lopez-Beltran, Enrique Gomez-Gomez, et al.
International Journal of Molecular Sciences|August 14, 2025
Omics-Mediated Treatment for Advanced Prostate Cancer: Moving Towards Precision OncologyYasra Fatima, Kirubel Nigusu Jobre, Enrique Gomez-Gomez, et al.
Cancers|April 13, 2023
Risk Classification of Bladder Cancer by Gene Expression and Molecular SubtypeAna Blanca, Antonio Lopez-Beltran, Kevin Lopez-Porcheron, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|June 25, 2019
Expression of miR-100 and miR-138 as prognostic biomarkers in non-muscle-invasive bladder cancerAna Blanca, Alvaro Sanchez-Gonzalez, Maria J Requena, et al.
European Urology Oncology|May 1, 2025
Prediction of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy by Collagen Models Using Multiomic ProfilesMaria Frantzi, Piotr Tymoszuk, Stefan Salcher, et al.
Diagnostics (Basel, Switzerland)|August 27, 2021
Does Adding Standard Systematic Biopsy to Targeted Prostate Biopsy in PI-RADS 3 to 5 Lesions Enhance the Detection of Clinically Significant Prostate Cancer? Should All Patients with PI-RADS 3 Undergo Targeted Biopsy?Enrique Gomez-Gomez, Sara Moreno Sorribas, Jose Valero-Rosa, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Current Opinion in Urology|September 25, 2023
Prognostic impact of serum testosterone in metastatic hormone-naive prostate cancer: a systematic review and meta-analysisIgnacio Puche-Sanz, Peter Chiu, Ana C Morillo, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|July 17, 2023
Midterm Outcomes of Kidney Transplantation from Expanded Criteria Donors After Circulatory Death: A Single-Center Retrospective Cohort StudyJoseba Salguero, Laura Chamorro, Enrique Gomez-Gomez, et al.
Scandinavian Journal of Urology|November 12, 2015
A tertiary experience of ileal-ureter substitution: Contemporary indications and outcomesEnrique Gomez-Gomez, Sachin Malde, Marco Spilotros, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|May 1, 2015
Perineostomy: the last oportunityJuan Carlos Regueiro Lopez, Enrique Gomez Gomez, Alberto Alonso Carrillo, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|February 26, 2025
Prognostic Significance of Programmed Cell Death-1, Programmed Cell Death-Ligand 1, Programmed Cell Death-Ligand 2, and Fibroblast Growth Factor Receptor 3 mRNA Expression in Bladder CancerAna Blanca, Antonio Lopez-Beltran, Enrique Gomez-Gomez, et al.
International Journal of Molecular Sciences|August 14, 2025
Omics-Mediated Treatment for Advanced Prostate Cancer: Moving Towards Precision OncologyYasra Fatima, Kirubel Nigusu Jobre, Enrique Gomez-Gomez, et al.
Cancers|April 13, 2023
Risk Classification of Bladder Cancer by Gene Expression and Molecular SubtypeAna Blanca, Antonio Lopez-Beltran, Kevin Lopez-Porcheron, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|June 25, 2019
Expression of miR-100 and miR-138 as prognostic biomarkers in non-muscle-invasive bladder cancerAna Blanca, Alvaro Sanchez-Gonzalez, Maria J Requena, et al.
European Urology Oncology|May 1, 2025
Prediction of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy by Collagen Models Using Multiomic ProfilesMaria Frantzi, Piotr Tymoszuk, Stefan Salcher, et al.
Diagnostics (Basel, Switzerland)|August 27, 2021
Does Adding Standard Systematic Biopsy to Targeted Prostate Biopsy in PI-RADS 3 to 5 Lesions Enhance the Detection of Clinically Significant Prostate Cancer? Should All Patients with PI-RADS 3 Undergo Targeted Biopsy?Enrique Gomez-Gomez, Sara Moreno Sorribas, Jose Valero-Rosa, et al.
Pageof 2